| Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry |
| |
| 作者姓名： | LIU Hai-bo XU Bo GAO Run-lin YANG Yue-jin YAO Min QIN Xue-wen WU Yong-jian YUAN Jin-qing MA Wei-hua QIAO Shu-bin CHEN Ji-lin |
| |
| 作者单位： | Cardiovascular Institute and Fuwai Hospital, Chinese Academy ofMedical Sciences, Peking Union Medical College, Beijing 100037,China |
| |
| 摘 要： | Recent clinical trials with rapamycin-eluting stents ,have shown very low restenosis rates.However, the higher penetration of drug eluting stent （DES） in China is being limited by the high costs of these imported devices, especially when considering multiple stenting. Firebird （Microport Co. Ltd., China） is a rapamycin （Huadong Pharmaceutical, China） polymer-based eluting stent with reasonable cost. The objective of this study was to evaluate the safety and efficacy of using Firebird stents in routine interventional practice.
|
| 关 键 词： | 雷帕霉素 药物洗脱支架 药物治疗 药物实验 |
| 收稿时间： | 2006-03-01 |
Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry |
| |
| LIU Hai-bo XU Bo GAO Run-lin YANG Yue-jin YAO Min QIN Xue-wen WU Yong-jian YUAN Jin-qing MA Wei-hua QIAO Shu-bin CHEN Ji-lin.Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry[J].Chinese Medical Journal,2006,119(7):609-611. |
| |
| Authors: | LIU;Hai-bo;XU;Bo;GAO;Run-lin;YANG;Yue-jin;YAO;Min;QIN;Xue-wen;WU;Yong-jian;YUAN;Jin-qing;MA;Wei-hua;QIAO;Shu-bin;CHEN;Ji-lin |
| |
| Abstract: | |
| |
| Keywords: | stents clinical trial percutanous coronary intervention |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息 |
| 点击此处可从《中华医学杂志(英文版)》下载免费的PDF全文 |
